Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-28Clinical Trial Results: Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver [Phase 2]
Phase 2 trial evaluating hepatic artery infusion pump chemotherapy with floxuridine and dexamethasone plus systemic chemotherapy in patients…
-
CLINICAL_TRIALS trial_result · 2026-08-26Clinical Trial Results: A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer [Phase 3]
Phase 3 trial comparing nivolumab-relatlimab fixed-dose combination against regorafenib or TAS-102 in later-line metastatic colorectal cance…
-
EMA approval · 2026-08-19EMA Authorised: Opdivo (nivolumab) — Bristol-Myers Squibb Pharma EEIG
European Medicines Agency authorises Opdivo (nivolumab) for multiple cancer indications, including melanoma, non-small cell lung cancer, ren…
-
CLINICAL_TRIALS trial_result · 2026-08-19Clinical Trial Update: The Effect of Discontinuation of Renin Angiotensin System Inhibitors on the Perioperative Myocardial Injury in Adult Patients Undergoing Colorectal Cancer Surgery [Phase 3]
Phase 3 trial evaluating discontinuation of renin-angiotensin system inhibitors on perioperative myocardial injury in adults undergoing colo…
-
CLINICAL_TRIALS trial_result · 2026-08-18Clinical Trial Results: Michigan Genetic Hereditary Testing (MiGHT) [NA]
Results from the MiGHT genetic hereditary testing trial conducted at University of Michigan Rogel Cancer Center in breast, colorectal, and o…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-08-13Clinical Trial Results: A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating NC410 plus pembrolizumab in advanced/metastatic solid tumors with various MSI statuses; terminated with posted re…
-
CLINICAL_TRIALS trial_result · 2026-08-07Clinical Trial Results: Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer. [Phase 2]
Phase 2 trial assessing safety and activity of PolyPEPI1018 in combination with atezolizumab in metastatic colorectal cancer completed with …
-
CLINICAL_TRIALS trial_result · 2026-07-28Clinical Trial Results: A Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer [Phase 2]
Phase 2 clinical trial results for CTX-009 in adults with metastatic colorectal cancer have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Update: Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10) [Phase 3]
Phase 3 study evaluating MRTX849 with cetuximab versus chemotherapy in advanced KRAS G12C-mutant colorectal cancer (KRYSTAL-10) is active no…
-
CLINICAL_TRIALS trial_result · 2026-07-22Clinical Trial Results: Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation [Phase 3]
Phase 3 trial comparing sotorasib and panitumumab versus investigator's choice in KRAS p.G12C-mutant colorectal cancer has completed with re…
-
CLINICAL_TRIALS trial_result · 2026-07-22Clinical Trial Results: Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial of Evorpacept (ALX148) combined with cetuximab and pembrolizumab in refractory microsatellite stable metastatic colorectal can…
-
CLINICAL_TRIALS trial_result · 2026-07-15Clinical Trial Results: Colonoscopy Outreach for Rural Communities Aim 2 [NA]
Completed clinical trial evaluating colonoscopy outreach in rural communities for colorectal cancer screening; results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-13Clinical Trial Results: A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer [Phase 1, Phase 2]
Phase 1/2 trial results for TC-510 in advanced mesothelin-expressing cancers were terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2026-07-06Clinical Trial Results: Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating Revumenib in colorectal cancer and other solid tumors has been terminated with results posted.
-
CLINICAL_TRIALS research · 2026-07-02Clinical Trial Results: Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health [NA]
Clinical trial results for adapting multiple behavior interventions to improve cancer survivor health; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-29Clinical Trial Results: Immunosurveillance for Metastatic Colorectal Cancer [Phase 2, Phase 3]
Clinical trial results for Immunosurveillance in metastatic colorectal cancer from Phase 2 and Phase 3 studies have been completed with resu…
-
CLINICAL_TRIALS trial_result · 2026-04-29Clinical Trial Results: Left Lateral Position Versus Supine Position in Colonoscopy [NA]
A completed clinical trial comparing left lateral position versus supine position during colonoscopy for colorectal cancer screening; result…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation [Phase 3]
Phase 3 trial comparing sotorasib and panitumumab versus investigator's choice for colorectal cancer with KRAS p.G12C mutation has completed…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10) [Phase 3]
Phase 3 trial evaluating MRTX849 with cetuximab versus chemotherapy in advanced colorectal cancer with KRAS G12C mutation is active/not recr…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation [Phase 3]
Phase 3 trial comparing sotorasib and panitumumab versus investigator's choice for colorectal cancer with KRAS p.G12C mutation has completed…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10) [Phase 3]
Phase 3 study evaluating MRTX849 with cetuximab versus chemotherapy in advanced KRAS G12C-mutant colorectal cancer is ongoing (ACTIVE_NOT_RE…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Neoadjuvant Prolgolimab Monotherapy in Locally Advanced MMR-deficient Colorectal Cancer [Phase 2]
Phase 2 trial update on neoadjuvant prologolimab monotherapy for locally advanced MMR-deficient colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer [Phase 2]
Phase 2 trial evaluating abemaciclib in combination with FOLFOX/FOLFIRI for patients with advanced colorectal liver metastases; currently en…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Effectiveness of Using Mobile Health Technology in Colorectal Cancer Screening Uptake [NA]
This clinical trial update reports the completed assessment of using mobile health technology to improve uptake of colorectal cancer screeni…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy [Phase 1]
Phase 1 study evaluating cabozantinib plus trifluridine/tipiracil (TAS-102) as salvage therapy in metastatic colorectal cancer has completed…